Home > Insider Trading > Filing (0000898432-21-000772)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325618	Iradimed Corp	IRMD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
898243	B James Hawkins	C/O Iradimed Corporation 1025 Willa Springs Dr. Winter Springs FL 32708		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-12-07	18,743	$1.48	36,011	No	4	A	Direct
Common Stock	Disposition	2021-12-07	18,743	$47.07	17,268	No	4	S	Direct
Common Stock	Acquisiton	2021-12-07	4,222	$0.00	21,490	No	4	M	Direct
Common Stock	Acquisiton	2021-12-08	559	$1.48	22,049	No	4	A	Direct
Common Stock	Disposition	2021-12-08	559	$48.50	21,490	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	M	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2021-12-07	18,743	$0.00	18,743	$1.48
Common Stock	Restricted Stock Units	Disposition	2021-12-07	4,222	$0.00	4,222	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2021-12-07	2,071	$0.00	2,071	$0.00
Common Stock	Stock Options (Right to Buy)	Disposition	2021-12-08	559	$0.00	559	$1.48

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2023-12-31	No	4	M	Direct
2,037		No	4	M	Direct
2,071		No	4	A	Direct
9,441	2023-12-31	No	4	M	Direct

Footnotes

This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
This transaction was executed in multiple trades at prices ranging from $46.30 to $48.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020 and 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
Restricted Stock Units convert to common stock on a one-for-one basis.
The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.